O'DONNELL; Niall

Patent Applications and Registrations

Patent applications and USPTO patent grants for O'DONNELL; Niall.The latest application filed is for "bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases".

Company Profile

5.11.28

O'DONNELL; Niall - Encintas CA
O'DONNELL; Niall - San Diego CA
O'Donnell; Niall - Encinitas CA
O'Donnell; Niall - St. Louis MO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases App 20220265649 - GEDULIN; Bronislava ; et al.	2022-08-25
Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases Grant 11,376,251 - Gedulin , et al. July 5, 2	2022-07-05
Use Of Ppar-delta Agonists In The Treatment Of Mitochondrial Myopathy App 20220117972 - O'CARROLL; Colin ; et al.	2022-04-21
Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases App 20220023296 - GEDULIN; Bronislava ; et al.	2022-01-27
Use Of A Ppar-delta Agonist In The Treatment Of Fatty Acid Oxidation Disorders (faod) App 20220023306 - O'CARROLL; Colin ; et al.	2022-01-27
Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases Grant 11,229,661 - Gedulin , et al. January 25, 2	2022-01-25
Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases App 20200246366 - Kind Code	2020-08-06
Bile Acid Recycling Inhibitors For Treatment Of Hypercholemia And Cholestatic Liver Disease App 20200207797 - GEDULIN; Bronislava ; et al.	2020-07-02
Method Of Treating Keloids Or Hypertrophic Scars Using Antisense Compounds Targeting Connective Tissue Growth Factor (ctgf) App 20200190521 - Dean; Nicholas M. ; et al.	2020-06-18
Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases App 20200069715 - GEDULIN; Bronislava ; et al.	2020-03-05
Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases Grant 10,512,657 - Gedulin , et al. Dec	2019-12-24
Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof App 20190323013 - Dean; Nicholas M. ; et al.	2019-10-24
Bile Acid Recycling Inhibitors For Treatment Of Hypercholemia And Cholestatic Liver Disease App 20190169217 - GEDULIN; Bronislava ; et al.	2019-06-06
Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases App 20170368085 - Gedulin; Bronislava ; et al.	2017-12-28
Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof App 20170335329 - Dean; Nicholas M. ; et al.	2017-11-23
Antisense oligonucleotides directed against connective tissue growth factor and uses thereof Grant 9,688,987 - Dean , et al. June 27, 2	2017-06-27
Method Of Treating Keloids Or Hypertrophic Scars Using Antisense Compounds Targeting Connective Tissue Growth Factor (ctgf) App 20170022501 - Dean; Nicholas M. ; et al.	2017-01-26
Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases App 20160310518 - Gedulin; Bronislava ; et al.	2016-10-27
Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof App 20150376623 - Dean; Nicholas M. ; et al.	2015-12-31
Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (CTGF) Grant 9,173,894 - Dean , et al. November 3, 2	2015-11-03
Antisense oligonucleotides directed against connective tissue growth factor and uses thereof Grant 9,096,851 - Dean , et al. August 4, 2	2015-08-04
Bile Acid Recycling Inhibitors For Treatment Of Hypercholemia And Cholestatic Liver Disease App 20140323412 - Gedulin; Bronislava ; et al.	2014-10-30
Bile Acid Recycling Inhibitors For Treatment Of Barrett's Esophagus And Gastroesophageal Reflux Disease App 20140271734 - GEDULIN; Bronislava ; et al.	2014-09-18
Bile Acid Recycling Inhibitors For Treatment Of Primary Sclerosing Cholangitis And Inflammatory Bowel Disease App 20140275090 - GEDULIN; Bronislava ; et al.	2014-09-18
Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases App 20140243281 - Gedulin; Bronislava ; et al.	2014-08-28
Methods for inhibiting expression of connective tissue growth factor Grant 8,772,260 - Dean , et al. July 8, 2	2014-07-08
Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases App 20130338093 - GEDULIN; Bronislava ; et al.	2013-12-19
Methods For Inhibiting Expression Of Connective Tissue Growth Factor App 20130190382 - Dean; Nicholas M. ; et al.	2013-07-25
Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof App 20130190380 - Dean; Nicholas M. ; et al.	2013-07-25
Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases App 20130109671 - GEDULIN; Bronislava ; et al.	2013-05-02
Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease App 20130108573 - GEDULIN; Bronislava ; et al.	2013-05-02
Method Of Treating Keloids Or Hypertrophic Scars Using Antisense Compounds Targeting Connective Tissue Growth Factor (ctgf) App 20120238937 - Dean; Nicholas M. ; et al.	2012-09-20
Antisense oligonucleotides directed against connective tissue growth factor and uses thereof Grant 8,252,762 - Dean , et al. August 28, 2	2012-08-28
Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor And Uses Thereof App 20100130595 - Dean; Nicholas M. ; et al.	2010-05-27

Company Registrations

SEC

0001780235

O'Donnell Niall

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.